Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community

Journal of Clinical Microbiology

Volumn 39, Issue 2, 2001, Pages 636-641

  Van Rie, A ^a   Warren, R ^a   Mshanga, I ^a   Jordaan, A M ^a   Van Der Spuy, G D ^a   Richardson, M ^a   Simpson, J ^a   Gie, R P ^a   Enarson, D A ^a   Beyers, N ^a   Van Helden, P D ^a   Victor, T C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ARTICLE; CODON; DOT HYBRIDIZATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; TUBERCULOSIS;

BACTERIAL PROTEINS; CLUSTER ANALYSIS; CODON; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MULTIPLE; GENOTYPE; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PEROXIDASES; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SOUTH AFRICA; SPUTUM; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0035126734     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.2.636-641.2001     Document Type: Article

References (26)

1. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods
2. Genetic methods for assessing antimicrobial resistance
3. Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis
4. Community based approaches to the control of multidrug resistant tuberculosis: Introducing "DOTS-plus"
5. A multi-institutional outbreak of highly drug-resistant tuberculosis: Epidemiology and clinical outcomes
6. Drug susceptibility testing of Mycobacterium tuberculosis: A neglected problem at the turn of the century
7. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: A molecular study
8. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas
9. A simple method of testing drug susceptibility of Mycobacterium tuberculosis: A report of an international collaborative study
10. A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia
11. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis
12. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods
13. rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy
14. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update
15. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level
16. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
17. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology
18. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment
19. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain among non-institutionalized, human immunodeficiency virus-seronegative patients
20. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy
21. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid
22. Tuberculosis drug resistance in the Western Cape
23. Characterization of rifampin resistance in pathogenic mycobacteria